// App-Quantinova.ai

PB0271 : Thrombosis risk in children with acute lymphoblastic leukimia during the therapy

Researchers

Presenter

  • E. Seregina

Principal Investigators

  • L. Zharikova

  • N. Trubina

  • M. Korsantiya

  • M. Gracheva

  • A. Poletaev

  • T. Vuimo

  • F. Ataullakhanov

Medical Centers

  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • D-dimer

  • Activated partial thromboplastin time

  • Antithrombin III

Drug/Treatment

  • Thrombomodulin alfa

  • endothelin-1

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved